Source: Glostem. AI-generated summary by biochip.com, published . Not independently reviewed.
Key takeaways
- Glostem lists Microfluidics and Lab-on-a-Chip India for June 10 and 11, 2027.
- Past MLC26 speakers included leaders from CSIR-CSIO, Nelson Mandela University, NIPER Hyderabad and biomedical industry.
- The page does not yet provide a 2027 venue, agenda, registration details, confirmed speakers, or submission deadlines.
Glostem has announced that Microfluidics and Lab-on-a-Chip India, also identified as MLOAC 2027, is scheduled for June 10 and 11, 2027. The event page says the conference is “Coming Soon,” so it currently provides dates and a record of speakers from the previous Microfluidics and Lab-on-a-Chip conference, MLC26, rather than a full 2027 agenda. Microfluidics is the science of guiding very small volumes of liquid through tiny channels, often no wider than a human hair. A lab-on-a-chip device puts several laboratory steps onto a compact chip, much as a smartphone combines a camera, map, and computer in one portable object. These technologies can be used to handle samples, mix reagents, separate materials, or measure biological and chemical signals with very little fluid. The listed past speakers span academic research, scientific instrumentation, pharmaceutical analysis, biomedical product development, and life-sciences operations. That mix suggests the meeting is intended as a forum for the practical path from microfluidic research to diagnostic, analytical, and industrial applications.
A 2027 Meeting With Details Still to Come
The Glostem page gives the conference dates as 10-06-2027 to 11-06-2027, which corresponds to June 10 and 11, 2027 in the day-month-year format commonly used in India. It does not yet state a venue, registration process, ticket cost, submission deadline, sponsor list, or confirmed MLOAC 2027 speakers.
That matters because conferences are not simply lecture series. They are working meeting points where researchers compare methods, companies assess technical needs, and early-stage developers seek collaborators who can help turn a prototype into a usable product. Until Glostem publishes a program, however, the specific themes and participation options for the 2027 event remain unconfirmed.
What Happens Inside a Lab-on-a-Chip
At ordinary laboratory scale, a test may require tubes, pipettes, centrifuges, trained operators, and several separate instruments. A lab-on-a-chip aims to shrink some of those functions into channels and chambers fabricated in a small device. Think of it as plumbing built at miniature scale: the channels direct liquid, while valves, surfaces, electric fields, or pressure can control what happens to it.
Using less liquid can be valuable when a sample is scarce or reagents are expensive. Small volumes can also move heat and chemicals differently than large containers do, which lets designers tightly control mixing and reactions. But miniaturization is not automatically easy: a useful device must still give reliable measurements, be manufacturable, and work consistently with real-world samples.
Past Speakers Point to a Broad Program
Glostem’s MLC26 speaker list includes Shantanu Bhattacharya, director of the Council of Scientific and Industrial Research Central Scientific Instruments Organisation in India. It also includes Paul Watts, research chair in microfluidic bio/chemical processing at Nelson Mandela University in South Africa, connecting the meeting to research on conducting biological and chemical processes at small scales.
Other listed speakers show the range of groups involved in this field. Amit Asthana is identified as professor and head of pharmaceutical analysis at the National Institute of Pharmaceutical Education and Research Hyderabad, while Harald Denz is listed as owner and chief executive of DENZ BIO-Medical GmbH in Austria. Gary Tarver is identified as site head at Chemveda Life Sciences in the United Kingdom, bringing a life-sciences industry perspective to the past program.
From Chips to Point-of-Care Testing
The page also includes a profile of Dr. Ragavendran Sivakumarasamy, described as a microfluidics and semiconductor process engineer with more than a decade of experience in cleanroom fabrication, nano-device integration, and biosensor platform development. Cleanrooms are tightly controlled manufacturing spaces designed to limit dust and contamination, conditions that are especially important when making tiny structures on chips.
Sivakumarasamy is founder and chief executive of Point-of-Care Microfluidics Pvt. Ltd., according to the profile. His company focuses on scalable lab-on-chip systems and point-of-care diagnostics, meaning tests designed to be used near a patient or sample rather than only in a centralized laboratory. The profile describes his work as spanning product development from concept and prototyping through validation and commercialization, with an emphasis on cost-effective diagnostic platforms.
Why Biosensors Are Central
A biosensor is a device that turns a biological interaction into a measurable signal. The everyday analogy is a smoke alarm: it does not merely encounter smoke, it converts that encounter into an alarm people can act on. In a diagnostic chip, the corresponding signal might indicate the presence of a molecule, ion, cell, or other feature in a sample.
The Glostem profile says Sivakumarasamy has published in journals including Nature Materials and Nano Letters, and attributes to him work on membrane-free ion detection systems and precision nanofabrication. Ions are electrically charged atoms or molecules, and detecting them can be important because they are involved in many chemical and biological processes. The page does not provide performance figures, clinical study results, or product-validation data for these systems.
Why This Matters
Microfluidics sits at an intersection of engineering, chemistry, biology, manufacturing, and healthcare. For a diagnostic device to leave the lab, its tiny channels and sensors must be paired with dependable sample handling, readable results, affordable production, and a workflow that suits users. A conference drawing people from instrumentation institutes, universities, pharmaceutical analysis, biomedical companies, and life-sciences operations can help expose where those requirements meet and where they still conflict.
The 2027 meeting may offer a useful window into how India’s microfluidics community is connecting scientific research with deployable tools. For now, the clearest facts are the two announced June dates and the breadth of expertise represented by MLC26 speakers. Prospective attendees, researchers, and companies will need to watch for Glostem’s future release of the venue, agenda, speaker roster, and registration details.